SARAH SCHAETTLE: Open Payments
NPI 1487749677 · MADISON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 30 payments from 14 companies in 2025. Trend: 2023 $345 · 2024 $824 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $179 |
| LivaNova USA, Inc. | 5 | $126 |
| ABBVIE INC. | 4 | $99 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Lundbeck LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| Alkermes, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: SPRAVATO, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, VRAYLAR, REXULTI, CAPLYTA, UZEDY, Auvelity, HETLIOZ.
Industry payments across WI — which companies pay providers there.
